1 January 2025 in Brazilian Journal of Medical and Biological Research
Preeclampsia (PE) is a disease of pregnancy characterized by the new onset of hypertension accompanied by proteinuria and/or other signs of maternal organ dysfunction that manifests after 20 weeks of gestation. MicroRNAs (miRNAs) are small non-coding RNAs (19-25 nucleotides) that function in the post-transcriptional regulation of gene expression. Many studies have suggested that different microRNA expression profiles may be associated with the development of PE. Hence, this study aims to report differentially expressed microRNAs that may be associated with the pathogenesis of PE and investigate whether different miRNA expression profiles are associated with different PE classifications and different phases of pregnancy. The bibliographic search was conducted from September 2021 to August 2024 and was performed on MEDLINE/PubMed, EMBASE, and Web of Science. This systematic review followed the methodological guidelines of the Cochrane Collaboration Manual for Systematic Intervention Reviews and was written according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Of the 1362 studies identified, 263 articles were selected as the sample of this study. The most frequently cited upregulated microRNAs were: miR-210, miR-155, miR-518b, miR-181a, miR-125b, miR-183, and miR-16. The most frequently cited downregulated microRNAs were: miR-363, miR-18a, miR-144, miR-149, miR-16, miR-18b, and miR-195. This study will serve as a reference to guide future experimental research. In addition, knowledge of the expression profiles of microRNAs associated with PE can help in the development of new protocols for early prediction of the disease.
14 March 2024 in Revista Brasileira de Ginecologia e Obstetrícia
Objective: To examine whether the DDAH2 promoter polymorphisms -1415G/A (rs2272592), -1151A/C (rs805304) and -449G/C (rs805305), and their haplotypes, are associated with PE compared with normotensive pregnant women, and whether they affect ADMA levels in these groups. Methods: A total of 208 pregnant women were included in the study and classified as early-onset (N=57) or […] Abstract Objective: To examine whether the DDAH2 promoter polymorphisms -1415G/A (rs2272592), -1151A/C (rs805304) and -449G/C (rs805305), and their haplotypes, are associated with PE compared with normotensive pregnant women, and whether they affect ADMA levels in these groups. Methods: A total of 208 pregnant women were included in the study and classified as early-onset (N=57) or […]
18 March 2025 in Revista Científica de Estética e Cosmetologia
Introdução: O envelhecimento cutâneo resulta da degradação progressiva da matriz extracelular e da diminuição da atividade dos fibroblastos, culminando em rugas, flacidez e perda de volume facial. Dentro da estética regenerativa, os bioestimuladores de colágeno Ácido Poli-L-Láctico (PLLA) e Hidroxiapatita de Cálcio (CaHA) destacam-se por sua capacidade de promover neocolagênese e melhorar a qualidade da pele. Objetivo: Este estudo teve como objetivo analisar as evidências científicas sobre os mecanismos de ação, indicações clínicas, eficácia e segurança desses dois biomateriais através dotratamento de rejuvenescimento facial dentro da prática da estética regenerativa. Materiais e Métodos: Trata-se de revisão com a finalidade de selecionar de forma sistemática, ordenada e abrangente os principais estudos e as evidências científicas encontradas sobre a temática escolhida. Discussão: Os estudos apontam que o Poli-L-Láctico (PLLA)atua de forma gradual, estimulando fibroblastos por meio de inflamação subclínica controlada, enquanto a Hidroxiapatita de cálcio (CaHA) oferece volumização imediata e bioestimulação com menor resposta inflamatória. Ambos demonstram boa segurança e eficácia, porém diferem quanto ao tempo de ação, propriedades físicas e indicações específicas. Conclusão: Tanto o Ácido Poli-L-Láctico (PLLA) quanto a Hidroxiapatita de Cálcio (CaHA) são alternativas eficazes no rejuvenescimento facial e a escolha entre eles deve considerar os objetivos terapêuticos, a anatomia tratada e o perfil individual do paciente, embora ainda haja necessidade de estudos comparativos mais robustos.